Mark B. Roth

Fundador en Faraday Pharmaceuticals, Inc. .

Health Technology

Retail Trade

Perfil

Mark B.
Roth is the founder of Faraday Pharmaceuticals, Inc. established in 2014, where he currently holds the position of President and Director.
He is also currently a Director at Faraday Pharmaceuticals, Inc. (Washington).

Cargos activos de Mark B. Roth

Empresas	Cargo	Inicio
Faraday Pharmaceuticals, Inc. Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA.	Fundador	01/01/2014
Faraday Pharmaceuticals, Inc. (Washington) Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA.	Director/Miembro de la Junta	-

Todos los cargos activos de Mark B. Roth

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mark B. Roth.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Faraday Pharmaceuticals, Inc. Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA.	Health Technology
Faraday Pharmaceuticals, Inc. (Washington) Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA.	Retail Trade